reference/22792192

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22792192

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	9
issn	1021-335X 1791-2431
issueIdentifier	5
pageRange	1395-9
publicationName	Oncology Reports
startingPage	1395
bibliographicCitation	Terakawa T, Miyake H, Kumano M, Sakai I, Fujisawa M. The antiandrogen bicalutamide activates the androgen receptor (AR) with a mutation in codon 741 through the mitogen activated protein kinase (MARK) pathway in human prostate cancer PC3 cells. Oncol Rep. 2010 Nov;24(5):1395–9. doi: 10.3892/or_00000998. PMID: 20878136.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5c387f88c2b83c85401676a0f4d701fc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_750e27ff50a198843644793502b2e583 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5b782bc55c38b6347e7885e1609bd40b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_87a03b162b11b996a593a3af8264ee41 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1721cb12e677c6d0d83ac2e060ee71b9
date	2010-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/20878136 https://doi.org/10.3892/or_00000998
isPartOf	https://portal.issn.org/resource/ISSN/1021-335X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20608 https://portal.issn.org/resource/ISSN/1791-2431
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	The antiandrogen bicalutamide activates the androgen receptor (AR) with a mutation in codon 741 through the mitogen activated protein kinase (MARK) pathway in human prostate cancer PC3 cells
discusses	http://id.nlm.nih.gov/mesh/M0004703 http://id.nlm.nih.gov/mesh/M0021712 http://id.nlm.nih.gov/mesh/M0001214 http://id.nlm.nih.gov/mesh/M0151653 http://id.nlm.nih.gov/mesh/M0001103 http://id.nlm.nih.gov/mesh/M0328039 http://id.nlm.nih.gov/mesh/M0014878 http://id.nlm.nih.gov/mesh/M0018556
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000813Q000494 http://id.nlm.nih.gov/mesh/D009570Q000494 http://id.nlm.nih.gov/mesh/D014105Q000494 http://id.nlm.nih.gov/mesh/D017354 http://id.nlm.nih.gov/mesh/D000726Q000494 http://id.nlm.nih.gov/mesh/D011471Q000235 http://id.nlm.nih.gov/mesh/D011471Q000188 http://id.nlm.nih.gov/mesh/D011944Q000378 http://id.nlm.nih.gov/mesh/D020935Q000187 http://id.nlm.nih.gov/mesh/D020928Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D003062 http://id.nlm.nih.gov/mesh/D011471Q000378 http://id.nlm.nih.gov/mesh/D011471Q000473 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D011944Q000235
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5328779 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6106 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_81b09498feb8998b851a4169d15a07f6 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.7.11.24 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472b28cee6c37ce9d58de4aa1dc6d7ef http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6305 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10635 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe0d872c4ea3e7d9f07488fc82841cc8 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_17511948551287f18397fc0a6fece217 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91649 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3973 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_dc144f4c6186201bd15b15f5feb99def http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a74d2c2148ca2ca6751f9ac69fa4582f http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c582dec943ff7b743aa0691df291cea6 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2375

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129153627 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129158112 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128501763 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129029179

Total number of triples: 70.